Amniotic fluid test could predict kidney survival in unborn babies

NCT ID NCT06912490

Recruiting now Diagnosis Sponsor: University Hospital, Toulouse Source: ClinicalTrials.gov ↗

First seen May 11, 2026 · Last updated May 22, 2026 · Updated 2 times

Summary

This study aims to validate a test that uses a 98-peptide signature in amniotic fluid to predict kidney function after birth in fetuses with congenital anomalies of the kidney and urinary tract (CAKUT). Researchers will collect samples from 78 pregnant women across France to see if the test can accurately predict which babies will need dialysis or survive to age 2. The goal is to improve prenatal counseling and management for families facing these conditions.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for KIDNEY DISEASES are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Children Hospital
RECRUITING

Toulouse, 31059, France

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact

Conditions

Explore the condition pages connected to this study.

KIDNEY DISEASES